MED Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

71.40M

-40%

-0.820

-920%

85.50M

-26.12%

-0.360

+414.29%

88.70M

-15.97%

-0.290

-231.82%

Estimates Revision

The market is revising Downward the revenue expectations for Medifast, Inc. (MED) for FY2025, with the revenue forecasts being adjusted by -0.7% over the past three months. During the same period, the stock price has changed by -13.94%.

Revenue Estimates for FY2025

Revise Downward

-0.7%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-86.67%

In Past 3 Month

Stock Price

Go Down

-13.94%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Medifast Inc (MED.N) is -6.15, compared to its 5-year average forward P/E of 10.99. For a more detailed relative valuation and DCF analysis to assess Medifast Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

10.99

Current PE

-6.15

Overvalued PE

77.09

Undervalued PE

-55.12

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

6.78

Current EV/EBITDA

4.35

Overvalued EV/EBITDA

10.57

Undervalued EV/EBITDA

2.99

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.95

Current PS

0.32

Overvalued PS

1.49

Undervalued PS

0.41

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

MED News & Events

Events Timeline

No data

News

8.0

2025-11-05NASDAQ.COM

Significant Wednesday Options Trading: RKLB, EAT, MED

4.5

2025-10-27Newsfilter

Medifast Unveils Strategic Transition to Focus on Metabolic Health with Launch of Metabolic Synchronization™

9.5

2025-10-21Newsfilter

Medifast to Release Third Quarter Financial Results for the Period Ending September 30, 2025

People Also Watch

Frequently Asked Questions

What is Medifast Inc (MED) stock price today?

The current price of MED is 11.42 USD — it has increased 3.54 % in the last trading day.

What is Medifast Inc (MED)'s business?

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

What is the price predicton of MED Stock?

Wall Street analysts forecast MED stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MED is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Medifast Inc (MED)'s revenue for the last quarter?

Medifast Inc revenue for the last quarter amounts to 89.41M USD, decreased -36.21 % YoY.

What is Medifast Inc (MED)'s earnings per share (EPS) for the last quarter?

Medifast Inc. EPS for the last quarter amounts to -0.21 USD, decreased -310.00 % YoY.

What changes have occurred in the market's expectations for Medifast Inc (MED)'s fundamentals?

How many employees does Medifast Inc (MED). have?

Medifast Inc (MED) has 504 emplpoyees as of January 10 2026.

What is Medifast Inc (MED) market cap?

Today MED has the market capitalization of 125.41M USD.